MRSH:NYSE
Marsh
Data as of 2026-03-10 - not real-time
$179.97
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Marsh & McLennan is trading close to its recent support level with the short‑term moving average beneath the mid‑term average, a pattern that typically signals bearish momentum. The MACD histogram remains positive, suggesting some underlying strength, while the RSI sits near the midpoint and volume has been on a downtrend, indicating a cautious market environment. Investor sentiment is at the extreme greed end of the spectrum, which can add short‑term volatility to an already fragile technical setup.
Fundamentally, the company continues to post solid revenue growth and healthy profit margins, supported by a strong return on equity and a payout ratio that leaves ample room for dividend sustainability. However, the discounted cash‑flow model points to a fair value well below the current market price, and the debt‑to‑equity ratio is elevated despite a sizable cash position. Analyst consensus remains neutral, and the dividend yield, while modest, is underpinned by robust cash flow. Together, these factors suggest the stock is overvalued in the near term but retains long‑term appeal for investors focused on earnings quality and dividend stability.
Fundamentally, the company continues to post solid revenue growth and healthy profit margins, supported by a strong return on equity and a payout ratio that leaves ample room for dividend sustainability. However, the discounted cash‑flow model points to a fair value well below the current market price, and the debt‑to‑equity ratio is elevated despite a sizable cash position. Analyst consensus remains neutral, and the dividend yield, while modest, is underpinned by robust cash flow. Together, these factors suggest the stock is overvalued in the near term but retains long‑term appeal for investors focused on earnings quality and dividend stability.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 6/10
Key Factors
- price near technical support
- decreasing volume trend
- positive MACD histogram
Medium Term
1–3 yearsbuy
Conviction: 7/10
Key Factors
- stable earnings growth
- strong cash flow generation
- sustainable dividend payout
Long Term
> 3 yearsbuy
Conviction: 8/10
Key Factors
- high return on equity
- robust market position in insurance brokerage
- long‑term dividend reliability
Key Metrics & Analysis
Financial Health
Revenue Growth8.70%
Profit Margin15.42%
P/E Ratio21.7
ROE29.35%
ROA7.51%
Debt/Equity140.05
P/B Ratio5.8
Op. Cash Flow$5.3B
Free Cash Flow$4.7B
Industry P/E17.4
Technical Analysis
TrendBearish
RSI46.0
Support$170.37
Resistance$187.77
MA 20$179.55
MA 50$182.69
MA 200$196.82
MACDBullish
VolumeDecreasing
Fear & Greed Index75.89
Valuation
Fair Value$155.18
Target Price$207.25
Upside/Downside15.16%
GradeOvervalued
TypeBlend
Dividend Yield1.97%
Risk Assessment
Beta0.35
Volatility33.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.